Joseph D. Khoury

Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype

Nitin Jain, Audrey L. Lamb, Susan O’Brien et al. · Blood · 2016 · 346 citations · Full text

Medicine, Hematology, Oncology +12

Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai–Dorfman disease

Sofía Garcés, L. Jeffrey Medeiros, Keyur P. Patel et al. · Modern Pathology · 2017 · 295 citations · Full text

Medicine, Genetics, Molecular Genetics +10

Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study

Elias Jabbour, Hagop M. Kantarjian, Farhad Ravandi et al. · The Lancet Oncology · 2015 · 280 citations

Medicine, Hematology, Oncology +13

Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study

Elias Jabbour, Nicholas J. Short, Farhad Ravandi et al. · The Lancet Haematology · 2018 · 270 citations · Full text

Medicine, Hematology, Oncology +12

Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study

Hagop M. Kantarjian, Farhad Ravandi, Nicholas J. Short et al. · The Lancet Oncology · 2018 · 241 citations · Full text

Medicine, Hematology, Oncology +13